Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation, but spare innate immune memory signature in endothelial cells
It has been shown that anti-inflammatory cytokines interleukin-35 (IL-35) and IL-10 could inhibit acute endothelial cell (EC) activation, however, it remains unknown if and by what pathways IL-35 and IL-10 could block atherogenic lipid lysophosphatidylcholine (LPC)-induced sustained EC activation; a...
Main Authors: | Xinyuan Li, Pu Fang, Yu Sun, Ying Shao, William Y. Yang, Xiaohua Jiang, Hong Wang, Xiaofeng Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Redox Biology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231719311875 |
Similar Items
-
Editorial: Endothelial cells as innate immune cells
by: Yifan Lu, et al.
Published: (2022-10-01) -
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology.
by: Uhlig, H, et al.
Published: (2006) -
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology
by: Uhlig, H, et al.
Published: (2007) -
Secretion of cytokines and chemokines by innate immune cells
by: Paige eLacy
Published: (2015-04-01) -
ROS signaling in innate immunity via oxidative protein modifications
by: Renuka Ramalingam Manoharan, et al.
Published: (2024-03-01)